Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantation

Atsushi Nonami, Katsuto Takenaka, Chinatsu Sumida, Kumiko Aizawa, Kenjiro Kamezaki, Toshihiro Miyamoto, Naoki Harada, Koji Nagafuji, Takanori Teshima, Mine Harada

研究成果: ジャーナルへの寄稿記事

25 引用 (Scopus)

抜粋

Behçet's disease is a chronic, relapsing, inflammatory disease of unknown origin. The association of myelodysplastic syndrome and Behçet's disease is rare, and recent reports have indicated that immunosuppressive agents alone are not sufficient to control Behçet's disease associated with MDS and many patients die of infection or hemorrhage. We report a case of MDS with intestinal Behçet's disease. We performed cord blood transplantation with a myeloablative regimen as the primary treatment. The patient achieved complete remission for both diseases, which continued for more than 16 months. Our experience suggests that CBT may provide a potent therapeutic option for the treatment of MDS-related Behçet's disease.

元の言語英語
ページ(範囲)1753-1756
ページ数4
ジャーナルInternal Medicine
46
発行部数20
DOI
出版物ステータス出版済み - 10 15 2007

All Science Journal Classification (ASJC) codes

  • Internal Medicine

フィンガープリント Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantation' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用